Literature DB >> 11297055

Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility.

A W Stange1, D E Hilmas, F J Furman, T R Gatliffe.   

Abstract

The prevalence of beryllium sensitization and chronic beryllium disease by job category was examined among individuals tested in the Rocky Flats Beryllium Health Surveillance Program. The program offered ongoing beryllium health surveillance for any current or former employee who believed they may have been exposed to beryllium at the Rocky Flats Environmental Technology Site. Of the 18,589 living individuals contacted, 7,573 requested participation and 6,614 (87.3%) eventually participated. Of this group, 78.2 percent were found to have verifiable job and building histories. The beryllium lymphocyte proliferation test was used to identify beryllium-sensitized individuals. Sensitization and chronic beryllium disease rates were analyzed with respect to gender, building work location(s), and length of employment at Rocky Flats. Several job categories and buildings were strongly associated with the 81 cases of chronic beryllium disease and the additional 154 cases of beryllium sensitization in this population. Beryllium sensitization was highest among beryllium machinists, 11.4 percent (odds ratio = 3.04, compared to the remainder of those tested, 95 % confidence interval = 1.48, 3.97) and health physics technicians, 11.9 percent (odds ratio = 2.87, 95% confidence interval = 1.12, 7.36). However, odds ratios were also increased among custodial employees, 5.64 percent (odds ratio = 1.30, 95% confidence interval = 0.92, 1.85) and other job titles that were thought to have only minimal potential for exposure to beryllium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297055     DOI: 10.1080/10473220118317

Source DB:  PubMed          Journal:  Appl Occup Environ Hyg        ISSN: 1047-322X


  9 in total

1.  Beryllium's public relations problem: protecting workers when there is no safe exposure level.

Authors:  David Michaels; Celeste Monforton
Journal:  Public Health Rep       Date:  2008 Jan-Feb       Impact factor: 2.792

2.  Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility.

Authors:  Carrie A Thomas; Rachel L Bailey; Michael S Kent; David C Deubner; Kathleen Kreiss; Christine R Schuler
Journal:  Public Health Rep       Date:  2009 Jul-Aug       Impact factor: 2.792

3.  Progression from beryllium exposure to chronic beryllium disease: an analytic model.

Authors:  Philip Harber; Siddharth Bansal; John Balmes
Journal:  Environ Health Perspect       Date:  2009-02-27       Impact factor: 9.031

4.  Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility.

Authors:  Mehrdad Arjomandi; James Seward; Michael B Gotway; Stephen Nishimura; George P Fulton; Josef Thundiyil; Talmadge E King; Philip Harber; John R Balmes
Journal:  J Occup Environ Med       Date:  2010-06       Impact factor: 2.162

Review 5.  Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.

Authors:  Amy S McKee; Shaikh M Atif; Michael T Falta; Andrew P Fontenot
Journal:  J Immunol       Date:  2022-04-15       Impact factor: 5.426

6.  The uses and adverse effects of beryllium on health.

Authors:  Ross G Cooper; Adrian P Harrison
Journal:  Indian J Occup Environ Med       Date:  2009-08

7.  Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program.

Authors:  Ellen P Donovan; Marc E Kolanz; David A Galbraith; Pamela S Chapman; Dennis J Paustenbach
Journal:  Int Arch Occup Environ Health       Date:  2007-05-05       Impact factor: 3.015

8.  Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.

Authors:  Margaret M Mroz; Lisa A Maier; Matthew Strand; Lori Silviera; Lee S Newman
Journal:  Am J Ind Med       Date:  2009-10       Impact factor: 2.214

9.  Chronic beryllium disease and sensitization at a beryllium processing facility.

Authors:  Kenneth Rosenman; Vicki Hertzberg; Carol Rice; Mary Jo Reilly; Judith Aronchick; John E Parker; Jackie Regovich; Milton Rossman
Journal:  Environ Health Perspect       Date:  2005-10       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.